Co-careldopa (Carbidopa/levodopa) Prescribing at GNOSALL
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
387
Total Quantity
53.6K
NHS Cost
£3.4K
vs National Avg
+71.2%
GNOSALL prescribed 387 items of Co-careldopa (Carbidopa/levodopa) over the last 12 months at a cost of £3,432 to the NHS. This is 71.2% above the national average prescribing rate. Co-careldopa (Carbidopa/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
36
Jul 2026
33
Jul 2026
35
Jul 2026
32
Jul 2026
29
Jul 2026
32
Jul 2026
28
Jul 2026
33
Jul 2026
30
Jul 2026
28
Jul 2026
38
Jul 2026
33
Prescribing Details
| Total Items | 387 |
|---|---|
| Total Quantity | 53,610 |
| Total NHS Cost | £3,432 |
| Presentations | 5 different forms |
| vs National Average | +71.2% |
Co-careldopa (Carbidopa/levodopa) Prescribing Comparison
| This practice | 387 items |
|---|---|
| National average per practice | 226 items |
| Difference | +71.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.